PGF and COVID-19: The sFlt-1/PlGF ratio in non-severe group was 30.7 ± 56.5, compared to 64.7 ± 53.5 for severe COVID-19 patients (SMD = −1.88; 95% CI: −3.77 to 0.01; p = 0.05).